| SC 13G/A | 2021-02-16 | Point72 Asset Management, L.P. | IMMUNOMEDICS INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2020-11-09 | BlackRock Inc. | IMMUNOMEDICS INC | 0 | 0.0% | EDGAR |
| SC 13D/A | 2020-10-23 | Avoro Capital Advisors LLC | IMMUNOMEDICS INC | - | 0.0% | EDGAR |
| SC 13G | 2020-04-16 | Point72 Asset Management, L.P. | IMMUNOMEDICS INC | 10,950,373 | 5.1% | EDGAR |
| SC 13G/A | 2020-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | IMMUNOMEDICS INC | 5,827,991 | 2.7% | EDGAR |
| SC 13G/A | 2020-02-12 | VANGUARD GROUP INC | IMMUNOMEDICS INC | 16,283,773 | 7.8% | EDGAR |
| SC 13G/A | 2020-02-07 | FMR LLC | IMMUNOMEDICS INC | 4,615,579 | 2.2% | EDGAR |
| SC 13G/A | 2020-02-05 | BlackRock Inc. | IMMUNOMEDICS INC | 14,696,596 | 7.1% | EDGAR |
| SC 13G/A | 2019-07-10 | FMR LLC | IMMUNOMEDICS INC | 12,676,130 | 6.6% | EDGAR |
| SC 13D/A | 2019-07-01 | Avoro Capital Advisors LLC | IMMUNOMEDICS INC | 21,000,000 | 11.0% | EDGAR |
| SC 13G | 2019-04-10 | FMR LLC | IMMUNOMEDICS INC | 22,867,854 | 12.0% | EDGAR |
| SC 13G | 2019-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | IMMUNOMEDICS INC | 12,815,023 | 6.7% | EDGAR |
| SC 13G/A | 2019-02-13 | ORBIMED ADVISORS LLC | IMMUNOMEDICS INC | 977,903 | 0.5% | EDGAR |
| SC 13G | 2019-02-11 | VANGUARD GROUP INC | IMMUNOMEDICS INC | 14,600,685 | 7.7% | EDGAR |
| SC 13G/A | 2019-02-04 | BlackRock Inc. | IMMUNOMEDICS INC | 12,639,350 | 6.6% | EDGAR |
| SC 13D/A | 2018-06-19 | venBio Select Advisor LLC | IMMUNOMEDICS INC | 17,714,461 | 9.9% | EDGAR |
| SC 13D/A | 2018-06-15 | venBio Select Advisor LLC | IMMUNOMEDICS INC | 17,514,461 | 9.8% | EDGAR |
| SC 13D/A | 2018-06-05 | SEATTLE GENETICS INC /WA | IMMUNOMEDICS INC | 8,282,804 | 4.9% | EDGAR |
| SC 13G/A | 2018-02-13 | ORBIMED ADVISORS LLC | IMMUNOMEDICS INC | 5,019,776 | 3.3% | EDGAR |
| SC 13G/A | 2018-01-25 | BlackRock Inc. | IMMUNOMEDICS INC | 9,064,259 | 6.0% | EDGAR |